We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Effect of platelet-rich plasma on dental stem cells derived from human impacted third molars

    Ui-Lyong Lee*

    Department of Oral & Maxillofacial Surgery, School of Dentistry, Seoul National University, 28 Youngun-dong Jongno-gu, Seoul 110–749, South Korea

    Tooth Bioengineering National Research Laboratory, BK21, School of Dentistry, Seoul National University, Seoul, Korea

    *Both authors contributed equally

    Search for more papers by this author

    ,
    Soung Hoo Jeon*

    Department of Oral & Maxillofacial Surgery, School of Dentistry, Seoul National University, 28 Youngun-dong Jongno-gu, Seoul 110–749, South Korea

    Tooth Bioengineering National Research Laboratory, BK21, School of Dentistry, Seoul National University, Seoul, Korea

    *Both authors contributed equally

    Search for more papers by this author

    ,
    Joo-Young Park

    Department of Oral & Maxillofacial Surgery, School of Dentistry, Seoul National University, 28 Youngun-dong Jongno-gu, Seoul 110–749, South Korea

    Tooth Bioengineering National Research Laboratory, BK21, School of Dentistry, Seoul National University, Seoul, Korea

    &
    Published Online:https://doi.org/10.2217/rme.10.96

    Aim: Platelet-rich plasma (PRP) is fabricated from autologous blood and extensively used to promote soft and hard tissue healing. In the dental field, autologous PRP is widely used combined with dental implant installation and bone graft. This study will evaluate the biologic effect of PRP on the proliferation and the differentiation of human dental stem cells, and find the key cytokines inducing these effects to estimate the clinical feasibility of PRP for dental tissue engineering. Materials & methods: Venous blood was obtained from four individuals and each PRP was fabricated. The human dental stem cells were obtained from the periodontal ligament (PDL) and dental pulp of the surgically extracted human third molars and expanded in vitro. Immunocytochemical staining and flow cytometry with STRO-1 and CD146 confirmed existence of mesenchymal stem cells in the PDL and dental pulp. The effect of PRP on the proliferation of PDL stem cells (PDLSCs) and dental pulp stem cells (DPSCs) was assessed by colony-forming ability measurement, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and bromodeoxyuridine incorporation assay. Alkaline phosphatase activity and calcium deposit were measured to evaluate the mineralization effect of PRP PDLSCs and DPSCs. Alizarin red S staining was used to detect mineral nodules. Odontogenic and osteogenic gene expressions were evaluated in the PRP-treated PDLSCs and DPSCs by real-time quantitative PCR. A protein array was performed to detect the key cytokines that have an important role in the tissue regenerative effect of PRP. Results: Flow cytometry cell sorting showed that the cells from human PDL and dental pulp contained mesenchymal stem cell populations. Colony-forming ability and cellular proliferation of the dental stem cells were increased at 0.5 and 1% PRP concentration but decreased at 5% concentration. Long-term treatment with 1% PRP enhanced proliferation of the human dental stem cells PDLSCs and DPSCs by 120 h and showed the most significant enhancement at 96 h. PRP also promoted mineralization differentiation of the two kinds of dental stem cells as shown by measurement of alkaline phosphatase activity and calcium deposit under mineralization conditioned media. Increased formation of mineral nodules stained with alizarin red was observed in both PDLSCs and DPSCs after treatment with 1% PRP. Real-time quantitative PCR showed higher odontogenic and osteogenic gene expressions in PRP-treated PDLSCs and DPSCs. RANTES/CCL5 and ICAM-1 were the two key cytokines that were detected in human cytokine array with PRP. Conclusion: The appropriate concentration of the PRP treatment enhanced proliferation and mineralization differentiation of human dental stem cells. RANTES/CCL5 and ICAM-1 might play an important role in PRP-induced tissue regeneration but further study is needed to investigate the whole mechanism.

    Bibliography

    • Pittenger MF, Mackay AM, Beck SC et al.: Multilineage potential of adult human mesenchymal stem cells. Science284,143–147 (1999).
    • Harada H, Kettunen P, Jung HS et al.: Localization of putative stem cells in dental epithelium and their association with Notch and FGF signaling. J. Cell. Biol.147,105–120 (1999).
    • Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ: Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats – similarities to astrocyte grafts. Proc. Natl. Acad. Sci. USA95,3908–3913 (1998).
    • Gronthos S, Brahim J, Li W et al.: Stem cell properties of human dental pulp stem cells. J. Dent. Res.81,531–535 (2002).
    • Seo BM, Miura M, Gronthos S et al.: Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet364,149–155 (2004).
    • Morsczeck C, Gotz W, Schierholz J et al.: Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth. Matrix Biol.24,155–165 (2005).
    • Kettunen P, Karavanova I, Thesleff I: Responsiveness of developing dental tissues to fibroblast growth factors: expression of splicing alternatives of FGFR1, -2, -3, and of FGFR4; and stimulation of cell proliferation by FGF-2, -4, -8, and -9. Dev. Genet.22,374–385 (1998).
    • Shiba H, Fujita T, Doi N et al.: Differential effects of various growth factors and cytokines on the syntheses of DNA, type I collagen, laminin, fibronectin, osteonectin/secreted protein, acidic and rich in cysteine (SPARC), and alkaline phosphatase by human pulp cells in culture. J. Cell. Physiol.174,194–205 (1998).
    • Onishi T, Kinoshita S, Shintani S, Sobue S, Ooshima T: Stimulation of proliferation and differentiation of dog dental pulp cells in serum-free culture medium by insulin-like growth factor. Arch. Oral Biol.44,361–371 (1999).
    • 10  Ouyang H, McCauley LK, Berry JE et al.: Response of immortalized murine cementoblasts/periodontal ligament cells to parathyroid hormone and parathyroid hormone-related protein in vitro. Arch. Oral Biol.45,293–303 (2000).
    • 11  Ohno S, Doi T, Fujimoto K et al.: RGD-CAP (betaig-h3) exerts a negative regulatory function on mineralization in the human periodontal ligament. J. Dent. Res.81,822–825 (2002).
    • 12  Marcopoulou CE, Vavouraki HN, Dereka XE, Vrotsos IA: Proliferative effect of growth factors TGF-β1, PDGF-BB and rhBMP-2 on human gingival fibroblasts and periodontal ligament cells. J. Int. Acad. Periodontol.5,63–70 (2003).
    • 13  Schilephake H: Bone growth factors in maxillofacial skeletal reconstruction. Int. J. Oral Maxillofac. Surg.31,469–484 (2002).
    • 14  Marx RE, Carlson ER, Eichstaedt RM et al.: Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.85,638–646 (1998).
    • 15  Shanaman R, Filstein MR, Danesh-Meyer MJ: Localized ridge augmentation using GBR and platelet-rich plasma: case reports. Int. J. Periodontics Restorative Dent.21,345–355 (2001).
    • 16  Lozada JL, Caplanis N, Proussaefs P, Willardsen J, Kammeyer G: Platelet-rich plasma application in sinus graft surgery: part I – Background and processing techniques. J. Oral Implantol.27,38–42 (2001).
    • 17  Lekovic V, Camargo PM, Weinlaender M, Vasilic N, Kenney EB: Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study. J. Periodontol.73,198–205 (2002).
    • 18  Kim SG, Chung CH, Kim YK, Park JC, Lim SC: Use of particulate dentin-plaster of Paris combination with/without platelet-rich plasma in the treatment of bone defects around implants. Int. J. Oral Maxillofac. Implants17,86–94 (2002).
    • 19  Anitua E: The use of plasma-rich growth factors (PRGF) in oral surgery. Pract. Proced. Aesthet. Dent.13,487–493; quiz 487–493 (2001).
    • 20  Landesberg R, Roy M, Glickman RS: Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. J. Oral Maxillofac. Surg.58,297–300; discussion 300–301 (2000).
    • 21  Kawase T, Okuda K, Saito Y et al.: Platelet-rich plasma provides nucleus for mineralization in cultures of partially differentiated periodontal ligament cells. In VitroCell. Dev. Biol. Anim.41,171–176 (2005).
    • 22  Lucarelli E, Beccheroni A, Donati D et al.: Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials24,3095–3100 (2003).
    • 23  Zhang Y, Zeng B, Zhang C, Yuan T: Effects of platelet-rich plasma on proliferation and osteogenetic activity of marrow mesenchymal stem cells in vitro. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi19,109–113 (2005).
    • 24  Ogino Y, Ayukawa Y, Tsukiyama Y, Koyano K: The effect of platelet-rich plasma on the cellular response of rat bone marrow cells in vitro. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.100,302–307 (2005).
    • 25  Bustin SA: Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol.25,169–193 (2000).
    • 26  Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ddCT method. Methods25,402–408 (2001).
    • 27  Covas, DT, Panepucci RA, Fontes AM et al.: Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profiles with CD146+ perivascular cells and fibroblasts. Exp. Hematol.36,642–654 (2008).
    • 28  Jo Y Y, Lee H J, Kook SY et al.: Isolation and characterization of postnatal stem cells from human dental tissues. Tissue Eng.13,767–773 (2007).
    • 29  Ferreira CF, Carriel Gomes MC, Filho JS et al.: Platelet-rich plasma influence on human osteoblasts growth. Clin. Oral Implants. Res.16,456–460 (2005).
    • 30  Choi BH, Zhu SJ, Kim BY et al.: Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in vitro study. Int. J. Oral Maxillofac. Surg.34,420–424 (2005).
    • 31  Kawase T, Okuda K, Wolff LF, Yoshie H: Platelet-rich plasma-derived fibrin clot formation stimulates collagen synthesis in periodontal ligament and osteoblastic cells in vitro. J. Periodontol.74,858–864 (2003).
    • 32  Kanno T, Takahashi T, Tsujisawa T, Ariyoshi W, Nishihara T: Platelet-rich plasma enhances human osteoblast-like cell proliferation and differentiation. J. Oral Maxillofac. Surg.63,362–369 (2005).
    • 33  Park JY, Jeon SH, Choung PH: Efficacy of periodontal stem cell transplantation in the treatment of advanced periodontitis. Cell Transplant. (2010) (Epub ahead of print).
    • 34  Cassiede P, Dennis JE, Ma F, Caplan AI: Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-β1 or PDGF-BB as assayed in vivo and in vitro. J. Bone Miner. Res.11,1264–1273 (1996).
    • 35  Hanada K, Dennis JE, Caplan AI: Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J. Bone Miner. Res.12,1606–1614 (1997).
    • 36  Giannobile WV, Whitson SW, Lynch SE: Noncoordinate control of bone formation displayed by growth factor combinations with IGF-I. J. Dent. Res.76,1569–1578 (1997).
    • 37  Mayahara H, Ito T, Nagai H et al.: In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors9,73–80 (1993).
    • 38  Mitlak BH, Finkelman RD, Hill EL et al.: The effect of systemically administered PDGF-BB on the rodent skeleton. J. Bone Miner. Res.11,238–247 (1996).
    • 39  Nakamura T, Hanada K, Tamura M et al.: Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology136,1276–1284 (1995).
    • 40  Boudreaux JM, Towler DA: Synergistic induction of osteocalcin gene expression: identification of a bipartite element conferring fibroblast growth factor 2 and cyclic AMP responsiveness in the rat osteocalcin promoter. J. Biol. Chem.271,7508–7515 (1996).
    • 41  Chaudhary LR, Avioli LV: Extracellular-signal regulated kinase signaling pathway mediates downregulation of type I procollagen gene expression by FGF-2, PDGF-BB, and okadaic acid in osteoblastic cells. J. Cell. Biochem.76,354–359 (2000).
    • 42  Hurley MM, Abreu C, Harrison JR et al.: Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J. Biol. Chem.268,5588–5593 (1993).
    • 43  Kawase T, Okuda K, Saito Y, Yoshie H: In vitro evidence that the biological effects of platelet-rich plasma on periodontal ligament cells is not mediated solely by constituent transforming-growth factor-β or platelet-derived growth factor. J. Periodontol.76,760–767 (2005).
    • 44  Struyf S, Menten P, Lenaerts JP et al.: Diverging binding capacities of natural LD78β isoforms of macrophage inflammatory protein-1α to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils. Eur. J. Immunol.31,2170–2178 (2001).
    • 45  Yang L, Froio RM, Sciuto TE et al.: ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-α-activated vascular endothelium under flow. Blood106,584–592 (2005).